Arginine vasopressin receptor
Arginine vasopressin receptor - the biologic effects of arginine vasopressin (avp) are mediated by 3 receptor subtypes: the v1a and v1b receptors that activate phospholipases via g alpha (q/11), and the v2 receptor that activates adenylyl cyclase by interacting with g alpha (s). This subfamily of g-protein coupled receptors also includes oxt receptors. Their activity is mediated by g proteins which stimulate a phosphatidylinositol-calcium second messenger system. All are involved in the control of body fluid osmolality, blood volume, blood pressure, and vascular tone. (from omim)
Resources[edit source]
Latest articles - Arginine vasopressin receptor
 | This medical article is a stub. You can help WikiMD by expanding it. |
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Arginine vasopressin receptor for any updates.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
